Home » Topics » Regulatory

Regulatory
RSS

Roche and Gilead Sciences to copromote hepatitis treatment in the U.S.

Oct. 4, 1996

Joint venture formed for development of oral heparin

Oct. 4, 1996

Schering-Plough seeks approval for corticosteroid nasal spray in rhinitis

Oct. 4, 1996

Atypical antipsychotic receives approvals

Oct. 4, 1996

First approval for a DTaP-IPV vaccine

Oct. 4, 1996

First combined hepatitis A/B vaccine approved

Sep. 27, 1996

New hay fever remedy available for the fall allergy season

Sep. 27, 1996

Orphan drug finally approved for urea cycle disorders

Sep. 27, 1996

First localized treatment for fatal brain cancer approved by the FDA

Sep. 27, 1996

Anika receives European marketing approval for osteoarthritis product

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.